OncoC4, Inc.
OncoC4 is a late-stage biopharma company developing cancer treatments, with a lead candidate in clinical trials. It has raised $50M and employs 69 people.
The growth story
OncoC4, Inc. grew from 29 to 69 employees between 2022 and 2026, raising $50M along the way, most recently a Series B in October 2025.
About
OncoC4 develops biologic drugs targeting cancer, with a focus on immune system pathways. Its lead drug, BNT316/ONC-392, is an anti-CTLA-4 antibody designed to balance tumor suppression and autoimmune protection. The company also has preclinical candidates targeting the CD24-Siglecs pathway.
Founded in 2020, OncoC4 has grown to 69 employees. Its $50M Series B funding in 2025 suggests ongoing clinical trial investments. The company's pipeline includes both late-stage and early-stage candidates, indicating a balanced approach to drug development.
Founders and leadership
OncoC4's largest function is research, with 16 employees dedicated to drug discovery and development. The company's leadership likely includes experienced biotech executives, given its late-stage clinical focus and $50M funding round.
The OncoC4, Inc. org chart
Yang Liu (Chairman, CEO and CSO) leads 32 mapped leaders with 4 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 31 (-14% YoY), Healthcare Services 7 (+75% YoY), Program and Project Management 6 (0% YoY), Operations 5 (0% YoY), Business Development 4 (0% YoY), Finance 3 (0% YoY).
Talent flow
OncoC4 recruits heavily from local medical and research institutions, with Children's National Hospital, ICON, and IQVIA being top sources. Employees tend to stay for a median of 2 years before moving to other biotech firms like Thermo Fisher Scientific or smaller startups.
Most common previous employers of OncoC4, Inc. staff: Children's National Hospital (5), ICON (4), IQVIA (4), ONCOIMMUNE (3), The National Institutes of Health (3), Institute of Human Virology at the University of Maryland School of Medicine (3). Former OncoC4, Inc. employees most often moved to Thermo Fisher Scientific (2), Gain Therapeutics (1), ClinExpert (1), General Oncology (1), NovaBridge Biosciences (1), FreeGCP.com (1).
The OncoC4, Inc. mafia
OncoC4 alumni have founded at least 3 companies, including Gain Therapeutics, NemaGen Discoveries, and FreeGCP.com. These startups range in size from 1 to 25 employees, showing entrepreneurial activity among former staff.
3Gene Mack, was Chief Financial Officer until 2021Martin Devenport, was Chief Operating Officer until 2024Andrew Michael, MD, was Medical Safety Officer, Clinical Development until 2023Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at OncoC4, Inc.: Clinical Research (19), Molecular Biology (18), Microsoft Office (17), Oncology (16), Research Skills (16), Clinical Trials (16), Data Analysis (15), Good Clinical Practice (GCP) (15).
Where the team actually sits
OncoC4, Inc. people are concentrated in Maryland, United States (21), Washington DC-Baltimore Area (11), United States (3), Texas, United States (2).
Search footprint
OncoC4, Inc. attracts about 81 organic search visits a month, traffic worth roughly $1K a month if bought through ads. It gained 34 ranking keywords and lost 16 in the last period.
What employees say
- Compensation
- 2.60 / 5
- Career opportunities
- 2.60 / 5
- Senior management
- 2.60 / 5
- Work-life balance
- 3.10 / 5
Frequently asked
OncoC4, Inc. has 69 employees as of September 2026.
OncoC4, Inc. has raised $50M in total, most recently a Series B round in October 2025.
Yang Liu (Chairman, CEO and CSO) sits at the top of OncoC4, Inc.'s reporting structure, with 4 direct reports.
The most common previous employers of current OncoC4, Inc. staff are Children's National Hospital (5 people), ICON (4 people), IQVIA (4 people).
Former OncoC4, Inc. employees most often move to Thermo Fisher Scientific (2), Gain Therapeutics (1), ClinExpert (1).
At least 3 companies have a founder who previously worked at OncoC4, Inc., including Gain Therapeutics, NemaGen Discoveries, FreeGCP.com.
OncoC4, Inc. attracts about 81 organic search visits a month, worth roughly $1K a month in equivalent ad spend.
The most common skills among OncoC4, Inc. staff are Clinical Research, Molecular Biology, Microsoft Office, Oncology, Research Skills.
OncoC4, Inc. staff are concentrated in Maryland, United States (21), Washington DC-Baltimore Area (11), United States (3).
OncoC4, Inc. has about 31 people in Research, down 14% over the past year, as of September 2026.
OncoC4, Inc. has about 7 people in Healthcare Services, up 75% over the past year, as of September 2026.
Computed from 50 current and 19 former OncoC4, Inc. profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.